The Biden administration's Medicare drug price negotiations promised savings for Americans, but a recent analysis shows they'll still pay far more than patients in other wealthy countries. Why are U.S. patients being charged double, triple, or even quadruple the amount for essential medications? When will drug prices in the U.S. be fair and affordable for all? Join the fight for lower drug prices and demand relief for all patients in need. #MedicareNegotiations #LowerDrugPrices #PatientsDeserveBetter
  • InevitableSwing [none/use name]
    ·
    2 months ago

    Reuters noted that in other countries, prices generally come down over time, but U.S. drugmakers are able to raise prices annually and often extend patents by making small changes to medications, stopping less expensive generic versions from hitting the market and saving patients money.

    Unlike in other wealthy countries, Johns Hopkins Bloomberg School of Public Health scientist Mariana Socal told Reuters, "the longer a drug is in the U.S. market, the more we pay."